statistiche ricercatore

Continente	#
NA - Nord America	490
AS - Asia	311
SA - Sud America	90
EU - Europa	87
Continente sconosciuto - Info sul continente non disponibili	9
AF - Africa	7
OC - Oceania	1
Totale	995

Nazione	#
US - Stati Uniti d'America	467
SG - Singapore	135
BR - Brasile	68
CN - Cina	63
VN - Vietnam	37
HK - Hong Kong	28
IT - Italia	21
IN - India	17
GB - Regno Unito	15
FI - Finlandia	14
CA - Canada	11
AR - Argentina	9
BD - Bangladesh	7
FR - Francia	7
DE - Germania	6
IE - Irlanda	5
ID - Indonesia	4
MX - Messico	4
CL - Cile	3
CO - Colombia	3
DO - Repubblica Dominicana	3
IQ - Iraq	3
RU - Federazione Russa	3
SV - El Salvador	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
EC - Ecuador	2
JP - Giappone	2
KG - Kirghizistan	2
LT - Lituania	2
NL - Olanda	2
PE - Perù	2
PL - Polonia	2
SE - Svezia	2
ZA - Sudafrica	2
AZ - Azerbaigian	1
BY - Bielorussia	1
CG - Congo	1
EG - Egitto	1
GR - Grecia	1
JM - Giamaica	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MA - Marocco	1
MN - Mongolia	1
MY - Malesia	1
NP - Nepal	1
NR - Nauru	1
PH - Filippine	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SI - Slovenia	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	986

Nome	#
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019	138
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33	111
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity	102
Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB	100
Tumor-Associated Macrophages: toward a better understanding of their cancer driver capability in Malignant Pleural Mesothelioma	81
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice	79
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy	79
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment	73
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma	62
Macrophages and cancer stem cells: a malevolent alliance	60
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset	58
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing	52
Totale	995

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	10	0	0	0	0	0	0	0	0	0	0	0	10
2022/2023	32	6	0	4	1	3	2	0	3	4	4	5	0
2023/2024	58	5	5	8	3	2	12	9	2	1	0	5	6
2024/2025	175	1	0	3	2	8	33	8	10	23	47	19	21
2025/2026	544	58	73	54	38	12	34	97	44	31	46	28	29
2026/2027	176	29	37	76	34	0	0	0	0	0	0	0	0
Totale													995